文献速递肝病

酒精性肝炎合并器官衰竭患者侵袭性真菌病负担研究

Burden of Invasive Fungal Diseases in Patients With Alcohol-Related Hepatitis and Organ Failure.
PubMed 文献 · Aliment Pharmacol Ther · 2025-09-01

该回顾性全国队列研究纳入法国2012-2021年11434例成人重症酒精性肝炎(CAH)患者,评估侵袭性真菌病(IFD)负担并与细菌性肺炎(BP)比较。结果显示2.2%发生IFD、15%发生BP,IFD患者3个月生存率仅17.5%,匹配分析中IFD与死亡风险增加约四倍相关,支持在CAH管理中实施靶向筛查和早期抗真菌策略。

要点

  • CAH患者中IFD发生率为2.2%,BP为15%,IFD患者3个月生存率仅17.5%。
  • BP增加IFD风险(aOR 2.93),匹配分析中IFD与死亡风险约四倍增加相关(aOR 4.58)。
  • 建议在CAH管理中参照BP实施靶向筛查和早期抗真菌策略。

核心结论

  • IFD影响约1/50的CAH患者,相比BP带来不成比例的高死亡风险。
  • 研究结果支持在CAH管理中实施靶向筛查和早期抗真菌策略,如同BP的处理。

研究设计与样本

  • 法国全国性回顾性队列研究,纳入2012-2021年成人CAH患者。
  • 共纳入11434例CAH患者,中位年龄55岁,72%为男性。
  • 主要暴露为IFD,主要结局为3个月死亡或肝移植。
  • 采用完整病例和倾向评分匹配队列分析调整比值比(aOR),并进行6周landmark分析和时依Cox模型。

主要发现

  • 2.2%的患者发生IFD,15%发生BP。
  • 3个月生存率:IFD患者17.5%(95%CI 13.0-23.0),BP患者46.8%(95%CI 44.3-49.3),两者均无者60.0%(95%CI 59.4-61.4),p<0.001。
  • 44.3%的BP患者发生IFD,BP增加IFD风险(aOR 2.93,95%CI 2.23-3.84)。
  • 匹配分析中IFD与死亡风险约四倍增加相关(aOR 4.58,95%CI 3.02-7.20),BP关联较低(aOR 1.23,95%CI 1.06-1.43)。
  • IFD是死亡的强时依预测因素。

临床怎么用

  • 在CAH管理中应考虑对IFD进行靶向筛查,并早期启动抗真菌治疗策略。
  • 合并BP的CAH患者IFD风险更高,应加强监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The burden of invasive fungal diseases (IFDs) in patients with complicated alcoholic hepatitis (CAH)-defined by ≥ 2 hepatic (ascites, jaundice, liver failure, encephalopathy) or extrahepatic (coagulopathy, shock, kidney or respiratory failure) dysfunctions within 30 days-remains poorly characterised. AIMS: To assess the burden of IFDs in CAH and compare it with bacterial pneumonia (BP). METHODS: We conducted a retrospective nationwide cohort study of adult CAH patients in France (2012-2021). The primary exposure were IFDs. The primary outcome was 3-month mortality or liver transplantation. Associations were assessed with adjusted odds ratios (aORs) in complete-case and propensity score-matched cohorts. A 6-week landmark analysis and time-dependent Cox models were used to evaluate time-varying effects. RESULTS: Among 11,434 CAH patients (median age 55 years; 72% male), 2.2% and 15% developed IFDs and BP, respectively. Three-month survival was 17.5% (95% CI: 13.0-23.0) in IFDs, 46.8% (44.3-49.3) in BP and 60.0% (59.4-61.4) in those without either (p < 0.001). IFDs occurred in 44.3% of patients with BP, and BP increased IFD risk (aOR 2.93, 95% CI: 2.23-3.84). In matched analyses, IFDs were associated with a fourfold increase in mortality (aOR 4.58, 95% CI: 3.02-7.20), while BP showed a lower association (aOR 1.23, 95% CI: 1.06-1.43). IFDs were strong time-dependent predictors of death. CONCLUSIONS: IFDs affected 1 in 50 CAH patients and carried a disproportionate mortality risk, compared with BP. These findings support the implementation of targeted screening and early antifungal strategies in CAH management, as for BP.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Mouliade C, Parlati L, Tzedakis S, et al. Burden of Invasive Fungal Diseases in Patients With Alcohol-Related Hepatitis and Organ Failure. Aliment Pharmacol Ther. 2025. PMID: 40890932. doi:10.1111/apt.70328

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。